[16, 17] RFA is one of the most recent local ablative therapies for small HCC[13, 14, 18], which can be performed by percutaneous or surgical approach.[19-21] For small HCC nodules (less than 3 cm), there is still some controversy regarding to the long-term effectiveness between the two treatment modalities, such http://www.selleckchem.com/products/GDC-0980-RG7422.html as overall survive time, disease-free time, and the tumor recurrence rate.[13, 22] The aim of
this randomized study was to determine which treatment modality, hepatectomy, or percutaneous RFA is more beneficial for patients with small HCC in terms of long-term outcomes. One hundred twenty patients with HCC ≤ 3 cm between January 1, 2000 and December 30, 2012 were randomized into either percutaneous RFA therapy or hepatectomy group, as initial treatment Selleckchem Enzalutamide in Sir Run Run Shaw Hospital. Sixty patients who received hepatectomy were treated at Department of General Surgery, and 60 patients who received
RFA were treated in Department of Medical Oncology. The treatment and data collection were approved by Ethical Committee of our institution. HCC diagnosis was based on the criteria used by the European Association for the Study of the Liver, confirmed by a core biopsy before therapy. This study included 88 men and 32 women with a median age of 53.4 ± 10.9 years (range: 18–71). All patients were Chinese. Inclusion criteria as follows: (i) ≥ 18 years; (ii) any solitary HCC ≤ 3 cm in diameter and no more than three tumor nodules; (iii) no extrahepatic metastasis at diagnosis; (iv)
no radiologic evidence of major portal/hepatic vein branches invasion; (v) liver function equal or better than Pugh–Child Class B, with no history of encephalopathy, ascites refractory to diuretics or variceal bleeding (Patients with Pugh–Child Class C could be enrolled after the liver function was improved to B with the treatment options, including find more albumin infusion, diuretics, and non-steroidal anti-inflammatory drugs); and (vi) platelet count > 50 × 109/L without clinical significant portal hypertension and esophageal varices. We compared the randomized analysis based on the clinical characteristics, including age, sex, Child–Pugh classification, hepatic cirrhosis, tumor anatomical location, and HBV infection. Sixty patients underwent hepatectomy for HCC. Hepatectomy procedures were performed based on the position of HCC under general anesthesia, including nonanatomic hepatectomy in 38 patients, right hepatectomy in 13 patients, and left hepatectomy in 9 patients. A nonanatomic resection aiming at a resection margin of at least 2 cm was performed.